Essity launches strategic review of Vinda and Consumer Tissue Private Label Europe
STOCKHOLM, April 26 (Reuters) - Hygiene products group
Essity ESSITYb.ST said on Wednesday it has initiated a
strategic review of its stake in Vinda 331.HK and its Consumer
Tissue Private Label Europe business.
The Swedish group said in a statement the aim of the review
is to reduce its Consumer Tissue division's share of group
sales.
(Reporting by Anna Ringstrom, editing by Terje Solsvik)
((anna.ringstrom@thomsonreuters.com; +46 8 502 423 74; Reuters
Messaging: anna.ringstrom.thomsonreuters.com@reuters.net))
Recent news on Vinda International Holdings
See all newsBrief: Vinda International Says Listing Of Shares On Stock Exchange Will Be Withdrawn From 16 August
Essity tweaks financial targets following Vinda divestment (updated)
Essity tweaks financial targets following Vinda divestment
Royal Golden Eagle to build Chinese fibre plant for $1.5 billion
Brief: Vinda International Says Li Chao Wang Resigned As Executive Director